Stevanato Group aims to expand distribution of EZ-fill whose proven advantages have turned its processing technology into an industry standard for Ready-To-Use products.

syringe-g66be12d39_1920

Over the last 12 years, more than 250 lines have been installed using Stevanato Group EZ-fill packaging technology. (Credit: MasterTux from Pixabay)

Stevanato Group, a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, and DWK Life Sciences, a leading global manufacturer and provider of precision labware as well as primary packaging solutions for Life Science Research, Diagnostics and Pharmaceutical markets, today announced they have entered a non-exclusive agreement for the distribution and sale of the EZ-fill Ready-to-Use solutions (RTU) by Stevanato Group.

The collaboration will leverage DWK Life Sciences’ experience in supplying a global network of laboratories and biopharma customers to broaden the distribution of Stevanato Group’s RTU EZ-fill products, including EZ-fill vials in Nest & Tub (N&T) and trays, and EZ-fill Cartridges in Nest & Tub.

RTU containment solutions allow pharmaceutical companies to maximize flexibility in aseptic filling using a common filling platform and can be integrated seamlessly into existing pharmaceutical manufacturing filling lines.

“We are pleased to welcome DWK Life Sciences as a distributor of our EZ-fill platform”, said Andrea Zambon, Corporate Business Development Senior Director of Stevanato Group. “Through DWK Life Sciences’ established, widespread and specialized network, Stevanato Group aims to broaden the reach of our EZ-fill products into the pharmaceutical ecosystem, from the laboratory to large-scale manufacturing.”

Over the last 12 years, more than 250 lines have been installed using Stevanato Group EZ-fill packaging technology. Adopted by many of the leading glass primary packaging suppliers worldwide, EZ-fill platform has become the market’s most established choice for pre-sterilized containers helping to ensure flexible and streamlined processability. Accommodating both small and large batch production, EZ-fill can improve drug packaging quality, reduce Total Cost of Ownership (TCO), and shorten overall time-to-market.

Michele Mora, Managing Director & Chief Business Officer for DWK Life Sciences, shared: “We are excited to partner with Stevanato Group to promote the EZ-fill portfolio and bring the leading RTU primary packaging platform to customers in the DWK Life Sciences global network. The introduction of the EZ-fill platform supports our strategy to expand best-in-class solutions and services from “Discovery to Delivery” that enable our customers to focus on their efforts to develop and commercialize biopharmaceuticals and therapeutics that improve patient lives.”

Source: Company Press Release